Announcements Trials
Browse Landscape

Phase

Phase 3 3

Status

Terminated 2Unknown 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Hepatitis B 3Carcinoma, Hepatocellular 3Lymphoma, B-Cell 1Lymphoma 1Hepatitis B, Chronic 1

Interventions

Tenofovir 3entecavir 2tenofovir alafenamide 1human papillomavirus vaccine, L1 type 16, 18 1Standard of Care 1Practice Guidelines as Topic 1Lamivudine 1Engerix-B 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Hepatitis B × Tenofovir × Clear all
NCT03887702 2024-05-20

Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors

SWOG Cancer Research Network

Phase 3 Terminated
4 enrolled 5 charts

Hepatitis B

NCT02186574 2019-12-12

Tenofovir to Prevent HBV Reactivation

University Health Network, Toronto

Phase 3 Unknown
184 enrolled
Lymphoid

Hepatitis B, Lymphoma

NCT01872988 2014-09-04

Tenofovir Antiviral Therapy Following Transarterial Chemoembolization for HBV Related Hepatocellular Carcinoma

Taichung Veterans General Hospital

Phase 3 Terminated
320 enrolled
Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular, Hepatitis B, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡